EndomeTRIO: The endometrium matters

• Women who have experienced implantation failure with morphologically good quality embryos. 
• Women with a history of recurrent pregnancy loss. 
• Women with a morphologically normal uterus and normal endometrial thickness (≥ 6 mm), where the uterus and endometrium are unlikely to be the problem. 
• Women with chronic Endometritis. 

EMMA/ALICE Limitations

• These tests are not able to detect resistance to antibiotics. 
• ALICE only detects the presence of pathogens associated with chronic endometritis. A negative result does not rule out the presence of other endometrial pathogens.
• The tests are not 100% accurate at determining the bacterial species. 

ERA Limitations

• There is a risk (<5%) to get a non-informative result, in which the biopsy procedure has failed to obtain a sufficient quantity and/or quality of tissue to be able to make a diagnosis. If this should occur a new biopsy will be required.
• The aim of this test Is to provide physicians with an objective molecular diagnosis of the patient´s endometrial timing of receptivity. Depending on the results of this test, the physician may use it as a guide for personalized embryo transfer.
• Pregnancy is not guaranteed, even with a receptive result. Poor embryo quality, genetic abnormalities, or previous pathologies can also reduce the likelihood of becoming pregnant.
• The ERA® does not test for any other endometrial pathology and does not asses or provide a prediction for the health of a subsequent pregnancy.